Similar to the NLRP3 inflammasome pathway, activated AIM2 forms an AIM2/ASC-pro-caspase 1 complex to trigger caspase 1-dependent IL-1β maturation [24], thereby causing more IL-1β release and aggravation of CRS. Here, AIM2 is linked to congenital rubella syndrome.